Benperidol

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Benperidol
Accession Number
DB12867
Type
Small Molecule
Groups
Investigational
Description

Benperidol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders, among others.

Structure
Thumb
Synonyms
Not Available
External IDs
MCN-JR-4584 / R-4584
Categories
UNII
97O6X78C53
CAS number
2062-84-2
Weight
Average: 381.451
Monoisotopic: 381.185255188
Chemical Formula
C22H24FN3O2
InChI Key
FEBOTPHFXYHVPL-UHFFFAOYSA-N
InChI
InChI=1S/C22H24FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-10,18H,3,6,11-15H2,(H,24,28)
IUPAC Name
1-(4-fluorophenyl)-4-[4-(2-hydroxy-1H-1,3-benzodiazol-1-yl)piperidin-1-yl]butan-1-one
SMILES
OC1=NC2=CC=CC=C2N1C1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1

Pharmacology

Indication
Not Available
Structured Indications
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
2,5-Dimethoxy-4-ethylamphetamineBenperidol may decrease the stimulatory activities of 2,5-Dimethoxy-4-ethylamphetamine.Experimental, Illicit
3,4-MethylenedioxyamphetamineBenperidol may decrease the stimulatory activities of 3,4-Methylenedioxyamphetamine.Experimental, Illicit
4-Bromo-2,5-dimethoxyamphetamineBenperidol may decrease the stimulatory activities of 4-Bromo-2,5-dimethoxyamphetamine.Experimental, Illicit
7-NitroindazoleThe risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Benperidol.Experimental
AcepromazineThe risk or severity of adverse effects can be increased when Acepromazine is combined with Benperidol.Approved, Vet Approved
AceprometazineThe risk or severity of adverse effects can be increased when Aceprometazine is combined with Benperidol.Approved
AdipiplonThe risk or severity of adverse effects can be increased when Adipiplon is combined with Benperidol.Investigational
AgomelatineThe risk or severity of adverse effects can be increased when Agomelatine is combined with Benperidol.Approved, Investigational
AlaproclateThe risk or severity of adverse effects can be increased when Benperidol is combined with Alaproclate.Experimental
AlfaxaloneThe risk or severity of adverse effects can be increased when Alfaxalone is combined with Benperidol.Vet Approved
AlfentanilThe risk or severity of adverse effects can be increased when Alfentanil is combined with Benperidol.Approved, Illicit
AllopregnanoloneThe risk or severity of adverse effects can be increased when Allopregnanolone is combined with Benperidol.Investigational
AlmotriptanThe risk or severity of adverse effects can be increased when Almotriptan is combined with Benperidol.Approved, Investigational
AlphacetylmethadolThe risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Benperidol.Experimental, Illicit
AlphaprodineThe risk or severity of adverse effects can be increased when Benperidol is combined with Alphaprodine.Illicit
AlprazolamThe risk or severity of adverse effects can be increased when Alprazolam is combined with Benperidol.Approved, Illicit, Investigational
AmisulprideThe risk or severity of adverse effects can be increased when Benperidol is combined with Amisulpride.Approved, Investigational
AmitriptylineThe risk or severity of adverse effects can be increased when Benperidol is combined with Amitriptyline.Approved
AmobarbitalThe risk or severity of adverse effects can be increased when Amobarbital is combined with Benperidol.Approved, Illicit
AmoxapineThe risk or severity of adverse effects can be increased when Benperidol is combined with Amoxapine.Approved
AmperozideThe risk or severity of adverse effects can be increased when Amperozide is combined with Benperidol.Experimental
AmphetamineBenperidol may decrease the stimulatory activities of Amphetamine.Approved, Illicit
AripiprazoleThe risk or severity of adverse effects can be increased when Aripiprazole is combined with Benperidol.Approved, Investigational
ArticaineThe risk or severity of adverse effects can be increased when Articaine is combined with Benperidol.Approved
AsenapineThe risk or severity of adverse effects can be increased when Asenapine is combined with Benperidol.Approved
AzaperoneThe risk or severity of adverse effects can be increased when Azaperone is combined with Benperidol.Vet Approved
AzelastineBenperidol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.Approved
BaclofenThe risk or severity of adverse effects can be increased when Benperidol is combined with Baclofen.Approved
BarbitalThe risk or severity of adverse effects can be increased when Barbital is combined with Benperidol.Illicit
BenzocaineThe risk or severity of adverse effects can be increased when Benzocaine is combined with Benperidol.Approved
BenzphetamineBenperidol may decrease the stimulatory activities of Benzphetamine.Approved, Illicit
Benzyl alcoholThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Benperidol.Approved
BrexpiprazoleThe risk or severity of adverse effects can be increased when Benperidol is combined with Brexpiprazole.Approved
BrimonidineBrimonidine may increase the central nervous system depressant (CNS depressant) activities of Benperidol.Approved
BromazepamThe risk or severity of adverse effects can be increased when Bromazepam is combined with Benperidol.Approved, Illicit
BromisovalThe risk or severity of adverse effects can be increased when Benperidol is combined with Bromisoval.Experimental
BromocriptineThe risk or severity of adverse effects can be increased when Bromocriptine is combined with Benperidol.Approved, Investigational
BromperidolThe risk or severity of adverse effects can be increased when Bromperidol is combined with Benperidol.Investigational
BrompheniramineThe risk or severity of adverse effects can be increased when Benperidol is combined with Brompheniramine.Approved
BrotizolamThe risk or severity of adverse effects can be increased when Brotizolam is combined with Benperidol.Approved, Withdrawn
BupivacaineThe risk or severity of adverse effects can be increased when Bupivacaine is combined with Benperidol.Approved, Investigational
BuprenorphineBenperidol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.Approved, Illicit, Investigational, Vet Approved
BuspironeThe risk or severity of adverse effects can be increased when Buspirone is combined with Benperidol.Approved, Investigational
ButabarbitalThe risk or severity of adverse effects can be increased when Butabarbital is combined with Benperidol.Approved, Illicit
ButacaineThe risk or severity of adverse effects can be increased when Butacaine is combined with Benperidol.Vet Approved
ButalbitalThe risk or severity of adverse effects can be increased when Benperidol is combined with Butalbital.Approved, Illicit
ButambenThe risk or severity of adverse effects can be increased when Butamben is combined with Benperidol.Approved
ButethalThe risk or severity of adverse effects can be increased when Butethal is combined with Benperidol.Approved, Illicit
ButorphanolThe risk or severity of adverse effects can be increased when Butorphanol is combined with Benperidol.Approved, Illicit, Vet Approved
CabergolineThe risk or severity of adverse effects can be increased when Cabergoline is combined with Benperidol.Approved
CanertinibThe risk or severity of adverse effects can be increased when Canertinib is combined with Benperidol.Investigational
CarbamazepineThe risk or severity of adverse effects can be increased when Carbamazepine is combined with Benperidol.Approved, Investigational
CarbinoxamineThe risk or severity of adverse effects can be increased when Benperidol is combined with Carbinoxamine.Approved
CarfentanilThe risk or severity of adverse effects can be increased when Carfentanil is combined with Benperidol.Illicit, Vet Approved
CarisoprodolThe risk or severity of adverse effects can be increased when Benperidol is combined with Carisoprodol.Approved
CetirizineThe risk or severity of adverse effects can be increased when Benperidol is combined with Cetirizine.Approved
Chloral hydrateThe risk or severity of adverse effects can be increased when Chloral hydrate is combined with Benperidol.Approved, Illicit, Vet Approved
ChlordiazepoxideThe risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Benperidol.Approved, Illicit
ChlormezanoneThe risk or severity of adverse effects can be increased when Chlormezanone is combined with Benperidol.Approved, Withdrawn
ChloroprocaineThe risk or severity of adverse effects can be increased when Chloroprocaine is combined with Benperidol.Approved
ChlorphenamineThe risk or severity of adverse effects can be increased when Benperidol is combined with Chlorphenamine.Approved
ChlorphentermineBenperidol may decrease the stimulatory activities of Chlorphentermine.Illicit, Withdrawn
ChlorpromazineThe risk or severity of adverse effects can be increased when Chlorpromazine is combined with Benperidol.Approved, Vet Approved
ChlorprothixeneThe risk or severity of adverse effects can be increased when Chlorprothixene is combined with Benperidol.Approved, Withdrawn
ChlorzoxazoneThe risk or severity of adverse effects can be increased when Benperidol is combined with Chlorzoxazone.Approved
CinchocaineThe risk or severity of adverse effects can be increased when Cinchocaine is combined with Benperidol.Approved, Vet Approved
CitalopramThe risk or severity of adverse effects can be increased when Citalopram is combined with Benperidol.Approved
ClemastineThe risk or severity of adverse effects can be increased when Benperidol is combined with Clemastine.Approved
ClidiniumThe risk or severity of adverse effects can be increased when Benperidol is combined with Clidinium.Approved
ClobazamThe risk or severity of adverse effects can be increased when Benperidol is combined with Clobazam.Approved, Illicit
clomethiazoleThe risk or severity of adverse effects can be increased when clomethiazole is combined with Benperidol.Investigational
ClomipramineThe risk or severity of adverse effects can be increased when Benperidol is combined with Clomipramine.Approved, Vet Approved
ClonazepamThe risk or severity of adverse effects can be increased when Benperidol is combined with Clonazepam.Approved, Illicit
ClonidineThe risk or severity of adverse effects can be increased when Benperidol is combined with Clonidine.Approved
ClopenthixolThe risk or severity of adverse effects can be increased when Benperidol is combined with Clopenthixol.Experimental
ClorazepateThe risk or severity of adverse effects can be increased when Clorazepate is combined with Benperidol.Approved, Illicit
ClothiapineThe risk or severity of adverse effects can be increased when Benperidol is combined with Clothiapine.Experimental
ClozapineThe risk or severity of adverse effects can be increased when Clozapine is combined with Benperidol.Approved
CocaineThe risk or severity of adverse effects can be increased when Cocaine is combined with Benperidol.Approved, Illicit
CodeineThe risk or severity of adverse effects can be increased when Codeine is combined with Benperidol.Approved, Illicit
CyclizineThe risk or severity of adverse effects can be increased when Benperidol is combined with Cyclizine.Approved
CyclobenzaprineThe risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Benperidol.Approved
CyproheptadineThe risk or severity of adverse effects can be increased when Benperidol is combined with Cyproheptadine.Approved
DantroleneThe risk or severity of adverse effects can be increased when Benperidol is combined with Dantrolene.Approved
DapiprazoleThe risk or severity of adverse effects can be increased when Dapiprazole is combined with Benperidol.Approved
DapoxetineThe risk or severity of adverse effects can be increased when Benperidol is combined with Dapoxetine.Investigational
DeramciclaneThe risk or severity of adverse effects can be increased when Deramciclane is combined with Benperidol.Investigational
DesfluraneThe risk or severity of adverse effects can be increased when Desflurane is combined with Benperidol.Approved
DesipramineThe risk or severity of adverse effects can be increased when Benperidol is combined with Desipramine.Approved
DesloratadineThe risk or severity of adverse effects can be increased when Benperidol is combined with Desloratadine.Approved, Investigational
DesvenlafaxineThe risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Benperidol.Approved
DetomidineThe risk or severity of adverse effects can be increased when Detomidine is combined with Benperidol.Vet Approved
DexbrompheniramineThe risk or severity of adverse effects can be increased when Benperidol is combined with Dexbrompheniramine.Approved
DexmedetomidineThe risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Benperidol.Approved, Vet Approved
DextroamphetamineBenperidol may decrease the stimulatory activities of Dextroamphetamine.Approved, Illicit
DextromethorphanThe risk or severity of adverse effects can be increased when Dextromethorphan is combined with Benperidol.Approved
DextromoramideThe risk or severity of adverse effects can be increased when Dextromoramide is combined with Benperidol.Experimental, Illicit
DextropropoxypheneThe risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Benperidol.Approved, Illicit, Withdrawn
DezocineThe risk or severity of adverse effects can be increased when Dezocine is combined with Benperidol.Approved
DiazepamThe risk or severity of adverse effects can be increased when Diazepam is combined with Benperidol.Approved, Illicit, Vet Approved
Diethyl etherThe risk or severity of adverse effects can be increased when Benperidol is combined with Diethyl ether.Experimental
DiethylpropionBenperidol may decrease the stimulatory activities of Diethylpropion.Approved, Illicit
DifenoxinThe risk or severity of adverse effects can be increased when Benperidol is combined with Difenoxin.Approved, Illicit
DihydrocodeineThe risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Benperidol.Approved, Illicit
DihydroergotamineThe risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Benperidol.Approved
DihydroetorphineThe risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Benperidol.Experimental, Illicit
DihydromorphineThe risk or severity of adverse effects can be increased when Dihydromorphine is combined with Benperidol.Experimental, Illicit
DimenhydrinateThe risk or severity of adverse effects can be increased when Benperidol is combined with Dimenhydrinate.Approved
DiphenhydramineThe risk or severity of adverse effects can be increased when Diphenhydramine is combined with Benperidol.Approved
DiphenoxylateThe risk or severity of adverse effects can be increased when Diphenoxylate is combined with Benperidol.Approved, Illicit
DixyrazineThe risk or severity of adverse effects can be increased when Benperidol is combined with Dixyrazine.Experimental
DoramectinThe risk or severity of adverse effects can be increased when Doramectin is combined with Benperidol.Vet Approved
DoxepinThe risk or severity of adverse effects can be increased when Benperidol is combined with Doxepin.Approved
DoxylamineDoxylamine may increase the central nervous system depressant (CNS depressant) activities of Benperidol.Approved, Vet Approved
DPDPEThe risk or severity of adverse effects can be increased when DPDPE is combined with Benperidol.Investigational
DronabinolDronabinol may increase the central nervous system depressant (CNS depressant) activities of Benperidol.Approved, Illicit
DroperidolDroperidol may increase the central nervous system depressant (CNS depressant) activities of Benperidol.Approved, Vet Approved
DrotebanolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Benperidol.Experimental, Illicit
DuloxetineThe risk or severity of adverse effects can be increased when Duloxetine is combined with Benperidol.Approved
DyclonineThe risk or severity of adverse effects can be increased when Dyclonine is combined with Benperidol.Approved
EcgonineThe risk or severity of adverse effects can be increased when Ecgonine is combined with Benperidol.Experimental, Illicit
EcopipamThe risk or severity of adverse effects can be increased when Ecopipam is combined with Benperidol.Investigational
EfavirenzThe risk or severity of adverse effects can be increased when Benperidol is combined with Efavirenz.Approved, Investigational
EletriptanThe risk or severity of adverse effects can be increased when Eletriptan is combined with Benperidol.Approved, Investigational
EltanoloneThe risk or severity of adverse effects can be increased when Eltanolone is combined with Benperidol.Investigational
EnfluraneThe risk or severity of adverse effects can be increased when Enflurane is combined with Benperidol.Approved, Vet Approved
EntacaponeThe risk or severity of adverse effects can be increased when Benperidol is combined with Entacapone.Approved, Investigational
Ergoloid mesylateThe risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Benperidol.Approved
ErgonovineThe risk or severity of adverse effects can be increased when Ergonovine is combined with Benperidol.Approved
ErgotamineThe risk or severity of adverse effects can be increased when Ergotamine is combined with Benperidol.Approved
EscitalopramThe risk or severity of adverse effects can be increased when Escitalopram is combined with Benperidol.Approved, Investigational
EstazolamThe risk or severity of adverse effects can be increased when Estazolam is combined with Benperidol.Approved, Illicit
EszopicloneThe risk or severity of adverse effects can be increased when Eszopiclone is combined with Benperidol.Approved
EthanolBenperidol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.Approved
EthchlorvynolThe risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Benperidol.Approved, Illicit, Withdrawn
EthosuximideThe risk or severity of adverse effects can be increased when Benperidol is combined with Ethosuximide.Approved
EthotoinThe risk or severity of adverse effects can be increased when Benperidol is combined with Ethotoin.Approved
Ethyl carbamateThe risk or severity of adverse effects can be increased when Ethyl carbamate is combined with Benperidol.Withdrawn
Ethyl chlorideThe risk or severity of adverse effects can be increased when Benperidol is combined with Ethyl chloride.Experimental
Ethyl loflazepateThe risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Benperidol.Approved, Illicit
EthylmorphineThe risk or severity of adverse effects can be increased when Ethylmorphine is combined with Benperidol.Approved, Illicit
EtidocaineThe risk or severity of adverse effects can be increased when Etidocaine is combined with Benperidol.Approved
EtifoxineThe risk or severity of adverse effects can be increased when Etifoxine is combined with Benperidol.Withdrawn
EtizolamThe risk or severity of adverse effects can be increased when Etizolam is combined with Benperidol.Approved
EtomidateThe risk or severity of adverse effects can be increased when Etomidate is combined with Benperidol.Approved
EtoperidoneThe risk or severity of adverse effects can be increased when Benperidol is combined with Etoperidone.Approved
EtorphineThe risk or severity of adverse effects can be increased when Etorphine is combined with Benperidol.Illicit, Vet Approved
EzogabineThe risk or severity of adverse effects can be increased when Benperidol is combined with Ezogabine.Approved
FelbamateThe risk or severity of adverse effects can be increased when Benperidol is combined with Felbamate.Approved
FencamfamineThe risk or severity of adverse effects can be increased when Fencamfamine is combined with Benperidol.Approved, Illicit, Withdrawn
FentanylThe risk or severity of adverse effects can be increased when Fentanyl is combined with Benperidol.Approved, Illicit, Investigational, Vet Approved
FexofenadineThe risk or severity of adverse effects can be increased when Benperidol is combined with Fexofenadine.Approved
FlibanserinThe risk or severity of adverse effects can be increased when Benperidol is combined with Flibanserin.Approved
FluanisoneThe risk or severity of adverse effects can be increased when Benperidol is combined with Fluanisone.Experimental
FludiazepamThe risk or severity of adverse effects can be increased when Fludiazepam is combined with Benperidol.Approved, Illicit
FlunarizineThe risk or severity of adverse effects can be increased when Benperidol is combined with Flunarizine.Approved
FlunitrazepamThe risk or severity of adverse effects can be increased when Flunitrazepam is combined with Benperidol.Approved, Illicit
FluoxetineThe risk or severity of adverse effects can be increased when Fluoxetine is combined with Benperidol.Approved, Vet Approved
FlupentixolThe risk or severity of adverse effects can be increased when Flupentixol is combined with Benperidol.Approved, Withdrawn
FluphenazineThe risk or severity of adverse effects can be increased when Fluphenazine is combined with Benperidol.Approved
FlurazepamThe risk or severity of adverse effects can be increased when Flurazepam is combined with Benperidol.Approved, Illicit
FluspirileneThe risk or severity of adverse effects can be increased when Fluspirilene is combined with Benperidol.Approved
Fluticasone propionateThe risk or severity of adverse effects can be increased when Benperidol is combined with Fluticasone propionate.Approved
FluvoxamineThe risk or severity of adverse effects can be increased when Fluvoxamine is combined with Benperidol.Approved, Investigational
FosphenytoinThe risk or severity of adverse effects can be increased when Benperidol is combined with Fosphenytoin.Approved
FospropofolThe risk or severity of adverse effects can be increased when Fospropofol is combined with Benperidol.Approved, Illicit
FrovatriptanThe risk or severity of adverse effects can be increased when Frovatriptan is combined with Benperidol.Approved, Investigational
GabapentinThe risk or severity of adverse effects can be increased when Gabapentin is combined with Benperidol.Approved, Investigational
Gabapentin EnacarbilThe risk or severity of adverse effects can be increased when Benperidol is combined with Gabapentin Enacarbil.Approved
Gamma Hydroxybutyric AcidThe risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Benperidol.Approved, Illicit
GepefrineBenperidol may decrease the stimulatory activities of Gepefrine.Experimental
GepironeThe risk or severity of adverse effects can be increased when Gepirone is combined with Benperidol.Investigational
GlutethimideThe risk or severity of adverse effects can be increased when Glutethimide is combined with Benperidol.Approved, Illicit
GuanfacineThe risk or severity of adverse effects can be increased when Benperidol is combined with Guanfacine.Approved, Investigational
HalazepamThe risk or severity of adverse effects can be increased when Halazepam is combined with Benperidol.Approved, Illicit, Withdrawn
HaloperidolThe risk or severity of adverse effects can be increased when Haloperidol is combined with Benperidol.Approved
HalothaneThe risk or severity of adverse effects can be increased when Halothane is combined with Benperidol.Approved, Vet Approved
HeroinThe risk or severity of adverse effects can be increased when Heroin is combined with Benperidol.Approved, Illicit
HexobarbitalThe risk or severity of adverse effects can be increased when Hexobarbital is combined with Benperidol.Approved
HydrocodoneBenperidol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.Approved, Illicit
HydromorphoneThe risk or severity of adverse effects can be increased when Hydromorphone is combined with Benperidol.Approved, Illicit
HydroxyamphetamineBenperidol may decrease the stimulatory activities of Hydroxyamphetamine.Approved
HydroxyzineHydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Benperidol.Approved
IloperidoneThe risk or severity of adverse effects can be increased when Benperidol is combined with Iloperidone.Approved
ImipramineThe risk or severity of adverse effects can be increased when Benperidol is combined with Imipramine.Approved
IndalpineThe risk or severity of adverse effects can be increased when Benperidol is combined with Indalpine.Investigational, Withdrawn
IndiplonThe risk or severity of adverse effects can be increased when Indiplon is combined with Benperidol.Investigational
Iofetamine I-123Benperidol may decrease the stimulatory activities of Iofetamine I-123.Approved
IsocarboxazidThe risk or severity of adverse effects can be increased when Isocarboxazid is combined with Benperidol.Approved
IsofluraneThe risk or severity of adverse effects can be increased when Isoflurane is combined with Benperidol.Approved, Vet Approved
KetamineThe risk or severity of adverse effects can be increased when Ketamine is combined with Benperidol.Approved, Vet Approved
KetazolamThe risk or severity of adverse effects can be increased when Ketazolam is combined with Benperidol.Approved
KetobemidoneThe risk or severity of adverse effects can be increased when Ketobemidone is combined with Benperidol.Approved
LamotrigineThe risk or severity of adverse effects can be increased when Benperidol is combined with Lamotrigine.Approved, Investigational
LevetiracetamThe risk or severity of adverse effects can be increased when Benperidol is combined with Levetiracetam.Approved, Investigational
LevobupivacaineThe risk or severity of adverse effects can be increased when Levobupivacaine is combined with Benperidol.Approved
LevocabastineThe risk or severity of adverse effects can be increased when Benperidol is combined with Levocabastine.Approved
LevocetirizineThe risk or severity of adverse effects can be increased when Benperidol is combined with Levocetirizine.Approved
LevodopaThe risk or severity of adverse effects can be increased when Benperidol is combined with Levodopa.Approved
Levomethadyl AcetateThe risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Benperidol.Approved
LevomilnacipranThe risk or severity of adverse effects can be increased when Levomilnacipran is combined with Benperidol.Approved
LevorphanolThe risk or severity of adverse effects can be increased when Levorphanol is combined with Benperidol.Approved
LidocaineThe risk or severity of adverse effects can be increased when Lidocaine is combined with Benperidol.Approved, Vet Approved
LinezolidThe risk or severity of adverse effects can be increased when Linezolid is combined with Benperidol.Approved, Investigational
LisdexamfetamineBenperidol may decrease the stimulatory activities of Lisdexamfetamine.Approved, Investigational
LithiumLithium may increase the neurotoxic activities of Benperidol.Approved
LofentanilThe risk or severity of adverse effects can be increased when Lofentanil is combined with Benperidol.Illicit
LoprazolamThe risk or severity of adverse effects can be increased when Benperidol is combined with Loprazolam.Experimental
LoratadineThe risk or severity of adverse effects can be increased when Benperidol is combined with Loratadine.Approved
LorazepamThe risk or severity of adverse effects can be increased when Lorazepam is combined with Benperidol.Approved
LorcaserinThe risk or severity of adverse effects can be increased when Lorcaserin is combined with Benperidol.Approved
LormetazepamThe risk or severity of adverse effects can be increased when Benperidol is combined with Lormetazepam.Approved
LoxapineThe risk or severity of adverse effects can be increased when Loxapine is combined with Benperidol.Approved
LurasidoneThe risk or severity of adverse effects can be increased when Lurasidone is combined with Benperidol.Approved
Magnesium SulfateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Benperidol.Approved, Vet Approved
MaprotilineThe risk or severity of adverse effects can be increased when Benperidol is combined with Maprotiline.Approved
MebicarThe risk or severity of adverse effects can be increased when Benperidol is combined with Mebicar.Experimental
MeclizineThe risk or severity of adverse effects can be increased when Benperidol is combined with Meclizine.Approved
MedazepamThe risk or severity of adverse effects can be increased when Benperidol is combined with Medazepam.Experimental
MedetomidineThe risk or severity of adverse effects can be increased when Medetomidine is combined with Benperidol.Vet Approved
MelatoninThe risk or severity of adverse effects can be increased when Melatonin is combined with Benperidol.Approved, Nutraceutical, Vet Approved
MelperoneThe risk or severity of adverse effects can be increased when Melperone is combined with Benperidol.Approved
MephedroneBenperidol may decrease the stimulatory activities of Mephedrone.Investigational
MephentermineBenperidol may decrease the stimulatory activities of Mephentermine.Approved
MepivacaineThe risk or severity of adverse effects can be increased when Mepivacaine is combined with Benperidol.Approved, Vet Approved
MeprobamateThe risk or severity of adverse effects can be increased when Meprobamate is combined with Benperidol.Approved, Illicit
MeptazinolThe risk or severity of adverse effects can be increased when Benperidol is combined with Meptazinol.Experimental
MequitazineBenperidol may increase the arrhythmogenic activities of Mequitazine.Approved
MesoridazineThe risk or severity of adverse effects can be increased when Mesoridazine is combined with Benperidol.Approved
MetaxaloneThe risk or severity of adverse effects can be increased when Benperidol is combined with Metaxalone.Approved
MethadoneThe risk or severity of adverse effects can be increased when Methadone is combined with Benperidol.Approved
Methadyl AcetateThe risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Benperidol.Approved, Illicit
MethamphetamineBenperidol may decrease the stimulatory activities of Methamphetamine.Approved, Illicit
MethapyrileneThe risk or severity of adverse effects can be increased when Methapyrilene is combined with Benperidol.Withdrawn
MethaqualoneThe risk or severity of adverse effects can be increased when Methaqualone is combined with Benperidol.Illicit, Withdrawn
MethocarbamolThe risk or severity of adverse effects can be increased when Benperidol is combined with Methocarbamol.Approved, Vet Approved
MethohexitalThe risk or severity of adverse effects can be increased when Methohexital is combined with Benperidol.Approved
MethotrimeprazineBenperidol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.Approved
MethoxyfluraneThe risk or severity of adverse effects can be increased when Methoxyflurane is combined with Benperidol.Approved, Vet Approved
MethoxyphenamineBenperidol may decrease the stimulatory activities of Methoxyphenamine.Experimental
MethsuximideThe risk or severity of adverse effects can be increased when Benperidol is combined with Methsuximide.Approved
MethylecgonineThe risk or severity of adverse effects can be increased when Methylecgonine is combined with Benperidol.Experimental
MethylphenidateThe risk or severity of adverse effects can be increased when Benperidol is combined with Methylphenidate.Approved, Investigational
MethylphenobarbitalThe risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Benperidol.Approved
MetoclopramideThe risk or severity of adverse effects can be increased when Metoclopramide is combined with Benperidol.Approved, Investigational
MetyrosineBenperidol may increase the sedative activities of Metyrosine.Approved
MidazolamThe risk or severity of adverse effects can be increased when Midazolam is combined with Benperidol.Approved, Illicit
MidomafetamineBenperidol may decrease the stimulatory activities of 3,4-Methylenedioxymethamphetamine.Experimental, Illicit
MilnacipranThe risk or severity of adverse effects can be increased when Milnacipran is combined with Benperidol.Approved
MinocyclineMinocycline may increase the central nervous system depressant (CNS depressant) activities of Benperidol.Approved, Investigational
MirtazapineBenperidol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.Approved
MMDABenperidol may decrease the stimulatory activities of MMDA.Experimental, Illicit
MoclobemideThe risk or severity of adverse effects can be increased when Moclobemide is combined with Benperidol.Approved
MolindoneThe risk or severity of adverse effects can be increased when Molindone is combined with Benperidol.Approved
MorphineThe risk or severity of adverse effects can be increased when Morphine is combined with Benperidol.Approved, Investigational
NabiloneNabilone may increase the central nervous system depressant (CNS depressant) activities of Benperidol.Approved, Investigational
NalbuphineThe risk or severity of adverse effects can be increased when Nalbuphine is combined with Benperidol.Approved
NaratriptanThe risk or severity of adverse effects can be increased when Naratriptan is combined with Benperidol.Approved, Investigational
NefazodoneThe risk or severity of adverse effects can be increased when Nefazodone is combined with Benperidol.Approved, Withdrawn
NitrazepamThe risk or severity of adverse effects can be increased when Nitrazepam is combined with Benperidol.Approved
Nitrous oxideThe risk or severity of adverse effects can be increased when Nitrous oxide is combined with Benperidol.Approved, Vet Approved
NorfluraneThe risk or severity of adverse effects can be increased when Benperidol is combined with Norflurane.Investigational
NormethadoneThe risk or severity of adverse effects can be increased when Normethadone is combined with Benperidol.Approved, Illicit
NortriptylineThe risk or severity of adverse effects can be increased when Benperidol is combined with Nortriptyline.Approved
OlanzapineThe risk or severity of adverse effects can be increased when Olanzapine is combined with Benperidol.Approved, Investigational
OlopatadineThe risk or severity of adverse effects can be increased when Benperidol is combined with Olopatadine.Approved
OndansetronThe risk or severity of adverse effects can be increased when Ondansetron is combined with Benperidol.Approved
OpiumThe risk or severity of adverse effects can be increased when Opium is combined with Benperidol.Approved, Illicit
OrphenadrineBenperidol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.Approved
OsanetantThe risk or severity of adverse effects can be increased when Osanetant is combined with Benperidol.Investigational
OxazepamThe risk or severity of adverse effects can be increased when Oxazepam is combined with Benperidol.Approved
OxethazaineThe risk or severity of adverse effects can be increased when Oxethazaine is combined with Benperidol.Investigational
OxprenololThe risk or severity of adverse effects can be increased when Oxprenolol is combined with Benperidol.Approved
OxybuprocaineThe risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Benperidol.Approved
OxycodoneThe risk or severity of adverse effects can be increased when Oxycodone is combined with Benperidol.Approved, Illicit, Investigational
OxymorphoneThe risk or severity of adverse effects can be increased when Oxymorphone is combined with Benperidol.Approved, Investigational, Vet Approved
PaliperidoneThe risk or severity of adverse effects can be increased when Paliperidone is combined with Benperidol.Approved
ParaldehydeBenperidol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.Approved
ParoxetineThe risk or severity of adverse effects can be increased when Paroxetine is combined with Benperidol.Approved, Investigational
PenfluridolThe risk or severity of adverse effects can be increased when Benperidol is combined with Penfluridol.Experimental
PentazocineThe risk or severity of adverse effects can be increased when Pentazocine is combined with Benperidol.Approved, Vet Approved
PentobarbitalThe risk or severity of adverse effects can be increased when Pentobarbital is combined with Benperidol.Approved, Vet Approved
PerampanelPerampanel may increase the central nervous system depressant (CNS depressant) activities of Benperidol.Approved
PerazineThe risk or severity of adverse effects can be increased when Perazine is combined with Benperidol.Investigational
PerospironeThe risk or severity of adverse effects can be increased when Perospirone is combined with Benperidol.Approved
PerphenazineThe risk or severity of adverse effects can be increased when Perphenazine is combined with Benperidol.Approved
PethidineThe risk or severity of adverse effects can be increased when Pethidine is combined with Benperidol.Approved
PhenazocineThe risk or severity of adverse effects can be increased when Benperidol is combined with Phenazocine.Experimental
PhenelzineThe risk or severity of adverse effects can be increased when Phenelzine is combined with Benperidol.Approved
PhenibutThe risk or severity of adverse effects can be increased when Benperidol is combined with Phenibut.Experimental
PhenobarbitalThe risk or severity of adverse effects can be increased when Phenobarbital is combined with Benperidol.Approved
PhenoperidineThe risk or severity of adverse effects can be increased when Benperidol is combined with Phenoperidine.Experimental
PhenoxyethanolThe risk or severity of adverse effects can be increased when Phenoxyethanol is combined with Benperidol.Approved
PhentermineBenperidol may decrease the stimulatory activities of Phentermine.Approved, Illicit
PhenytoinThe risk or severity of adverse effects can be increased when Benperidol is combined with Phenytoin.Approved, Vet Approved
PimozideThe risk or severity of adverse effects can be increased when Pimozide is combined with Benperidol.Approved
PipamperoneThe risk or severity of adverse effects can be increased when Pipamperone is combined with Benperidol.Approved
PipotiazineThe risk or severity of adverse effects can be increased when Benperidol is combined with Pipotiazine.Approved
PiritramideThe risk or severity of adverse effects can be increased when Piritramide is combined with Benperidol.Investigational
PizotifenThe risk or severity of adverse effects can be increased when Benperidol is combined with Pizotifen.Approved
PomalidomideThe risk or severity of adverse effects can be increased when Benperidol is combined with Pomalidomide.Approved
PramipexoleBenperidol may increase the sedative activities of Pramipexole.Approved, Investigational
PramocaineThe risk or severity of adverse effects can be increased when Pramocaine is combined with Benperidol.Approved
PrazepamThe risk or severity of adverse effects can be increased when Prazepam is combined with Benperidol.Approved, Illicit
PregabalinThe risk or severity of adverse effects can be increased when Pregabalin is combined with Benperidol.Approved, Illicit, Investigational
PrilocaineThe risk or severity of adverse effects can be increased when Prilocaine is combined with Benperidol.Approved
PrimidoneThe risk or severity of adverse effects can be increased when Benperidol is combined with Primidone.Approved, Vet Approved
ProcaineThe risk or severity of adverse effects can be increased when Procaine is combined with Benperidol.Approved, Investigational, Vet Approved
ProcarbazineThe risk or severity of adverse effects can be increased when Procarbazine is combined with Benperidol.Approved
ProchlorperazineThe risk or severity of adverse effects can be increased when Prochlorperazine is combined with Benperidol.Approved, Vet Approved
PromazineThe risk or severity of adverse effects can be increased when Promazine is combined with Benperidol.Approved, Vet Approved
PromethazineThe risk or severity of adverse effects can be increased when Benperidol is combined with Promethazine.Approved
PropanididThe risk or severity of adverse effects can be increased when Benperidol is combined with Propanidid.Experimental
ProparacaineThe risk or severity of adverse effects can be increased when Proparacaine is combined with Benperidol.Approved, Vet Approved
PropofolThe risk or severity of adverse effects can be increased when Propofol is combined with Benperidol.Approved, Investigational, Vet Approved
PropoxycaineThe risk or severity of adverse effects can be increased when Propoxycaine is combined with Benperidol.Approved
ProtriptylineThe risk or severity of adverse effects can be increased when Benperidol is combined with Protriptyline.Approved
ProxibarbalThe risk or severity of adverse effects can be increased when Benperidol is combined with Proxibarbal.Experimental
PSD502The risk or severity of adverse effects can be increased when PSD502 is combined with Benperidol.Investigational
PseudoephedrineBenperidol may decrease the stimulatory activities of Pseudoephedrine.Approved
QuazepamThe risk or severity of adverse effects can be increased when Quazepam is combined with Benperidol.Approved, Illicit
QuetiapineThe risk or severity of adverse effects can be increased when Quetiapine is combined with Benperidol.Approved
QuinagolideThe therapeutic efficacy of Quinagolide can be decreased when used in combination with Benperidol.Approved
QuinisocaineThe risk or severity of adverse effects can be increased when Benperidol is combined with Quinisocaine.Experimental
RacloprideThe risk or severity of adverse effects can be increased when Raclopride is combined with Benperidol.Investigational
RamelteonThe risk or severity of adverse effects can be increased when Benperidol is combined with Ramelteon.Approved, Investigational
RasagilineThe risk or severity of adverse effects can be increased when Rasagiline is combined with Benperidol.Approved
RemifentanilThe risk or severity of adverse effects can be increased when Remifentanil is combined with Benperidol.Approved
RemoxiprideThe risk or severity of adverse effects can be increased when Remoxipride is combined with Benperidol.Approved, Withdrawn
ReserpineThe risk or severity of adverse effects can be increased when Reserpine is combined with Benperidol.Approved
RisperidoneThe risk or severity of adverse effects can be increased when Risperidone is combined with Benperidol.Approved, Investigational
RitanserinThe risk or severity of adverse effects can be increased when Ritanserin is combined with Benperidol.Investigational
RitobegronBenperidol may decrease the stimulatory activities of Ritobegron.Investigational
RizatriptanThe risk or severity of adverse effects can be increased when Rizatriptan is combined with Benperidol.Approved
RomifidineThe risk or severity of adverse effects can be increased when Romifidine is combined with Benperidol.Vet Approved
RopiniroleBenperidol may increase the sedative activities of Ropinirole.Approved, Investigational
RopivacaineThe risk or severity of adverse effects can be increased when Ropivacaine is combined with Benperidol.Approved
RotigotineBenperidol may increase the sedative activities of Rotigotine.Approved
RufinamideThe risk or severity of adverse effects can be increased when Rufinamide is combined with Benperidol.Approved
ScopolamineThe risk or severity of adverse effects can be increased when Benperidol is combined with Scopolamine.Approved
SecobarbitalThe risk or severity of adverse effects can be increased when Secobarbital is combined with Benperidol.Approved, Vet Approved
SelegilineThe risk or severity of adverse effects can be increased when Selegiline is combined with Benperidol.Approved, Investigational, Vet Approved
SepranoloneThe risk or severity of adverse effects can be increased when Benperidol is combined with Sepranolone.Investigational
SertindoleThe risk or severity of adverse effects can be increased when Sertindole is combined with Benperidol.Approved, Withdrawn
SertralineThe risk or severity of adverse effects can be increased when Sertraline is combined with Benperidol.Approved
SevofluraneThe risk or severity of adverse effects can be increased when Sevoflurane is combined with Benperidol.Approved, Vet Approved
Sodium oxybateSodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Benperidol.Approved
StiripentolThe risk or severity of adverse effects can be increased when Benperidol is combined with Stiripentol.Approved
SufentanilThe risk or severity of adverse effects can be increased when Sufentanil is combined with Benperidol.Approved, Investigational
SulpirideThe risk or severity of adverse effects can be increased when Benperidol is combined with Sulpiride.Approved
SultoprideThe risk or severity of adverse effects can be increased when Benperidol is combined with Sultopride.Experimental
SumatriptanThe risk or severity of adverse effects can be increased when Sumatriptan is combined with Benperidol.Approved, Investigational
SuvorexantBenperidol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.Approved
TandospironeThe risk or severity of adverse effects can be increased when Tandospirone is combined with Benperidol.Investigational
TapentadolTapentadol may increase the central nervous system depressant (CNS depressant) activities of Benperidol.Approved
TasimelteonThe risk or severity of adverse effects can be increased when Benperidol is combined with Tasimelteon.Approved
Tedizolid PhosphateThe risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Benperidol.Approved
TemazepamThe risk or severity of adverse effects can be increased when Temazepam is combined with Benperidol.Approved
TetrabenazineThe risk or severity of adverse effects can be increased when Tetrabenazine is combined with Benperidol.Approved
TetracaineThe risk or severity of adverse effects can be increased when Tetracaine is combined with Benperidol.Approved, Vet Approved
TetrahydropalmatineThe risk or severity of adverse effects can be increased when Tetrahydropalmatine is combined with Benperidol.Investigational
TetrodotoxinThe risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Benperidol.Investigational
ThalidomideBenperidol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.Approved, Investigational, Withdrawn
ThiamylalThe risk or severity of adverse effects can be increased when Thiamylal is combined with Benperidol.Approved, Vet Approved
ThiopentalThe risk or severity of adverse effects can be increased when Thiopental is combined with Benperidol.Approved, Vet Approved
ThioridazineThe risk or severity of adverse effects can be increased when Thioridazine is combined with Benperidol.Withdrawn
ThiothixeneThe risk or severity of adverse effects can be increased when Thiothixene is combined with Benperidol.Approved
TiagabineThe risk or severity of adverse effects can be increased when Benperidol is combined with Tiagabine.Approved
TiaprideThe risk or severity of adverse effects can be increased when Benperidol is combined with Tiapride.Approved, Investigational
TiletamineThe risk or severity of adverse effects can be increased when Tiletamine is combined with Benperidol.Vet Approved
TilidineThe risk or severity of adverse effects can be increased when Benperidol is combined with Tilidine.Experimental
TizanidineThe risk or severity of adverse effects can be increased when Benperidol is combined with Tizanidine.Approved
TolcaponeThe risk or severity of adverse effects can be increased when Benperidol is combined with Tolcapone.Approved, Withdrawn
TopiramateThe risk or severity of adverse effects can be increased when Benperidol is combined with Topiramate.Approved
TramadolThe risk or severity of adverse effects can be increased when Tramadol is combined with Benperidol.Approved, Investigational
Trans-2-PhenylcyclopropylamineThe risk or severity of adverse effects can be increased when Trans-2-Phenylcyclopropylamine is combined with Benperidol.Experimental
TranylcypromineThe risk or severity of adverse effects can be increased when Tranylcypromine is combined with Benperidol.Approved
TrazodoneThe risk or severity of adverse effects can be increased when Trazodone is combined with Benperidol.Approved, Investigational
TriazolamThe risk or severity of adverse effects can be increased when Triazolam is combined with Benperidol.Approved
Tricaine methanesulfonateThe risk or severity of adverse effects can be increased when Tricaine methanesulfonate is combined with Benperidol.Vet Approved
TrichloroethyleneThe risk or severity of adverse effects can be increased when Benperidol is combined with Trichloroethylene.Experimental
TrifluoperazineThe risk or severity of adverse effects can be increased when Trifluoperazine is combined with Benperidol.Approved
TrifluperidolThe risk or severity of adverse effects can be increased when Benperidol is combined with Trifluperidol.Experimental
TriflupromazineThe risk or severity of adverse effects can be increased when Triflupromazine is combined with Benperidol.Approved, Vet Approved
TrimipramineThe risk or severity of adverse effects can be increased when Benperidol is combined with Trimipramine.Approved
TriprolidineThe risk or severity of adverse effects can be increased when Benperidol is combined with Triprolidine.Approved
Valproic AcidThe risk or severity of adverse effects can be increased when Valproic Acid is combined with Benperidol.Approved, Investigational
VenlafaxineThe risk or severity of adverse effects can be increased when Venlafaxine is combined with Benperidol.Approved
VeraliprideThe risk or severity of adverse effects can be increased when Benperidol is combined with Veralipride.Experimental
VigabatrinThe risk or severity of adverse effects can be increased when Benperidol is combined with Vigabatrin.Approved
VilazodoneThe risk or severity of adverse effects can be increased when Vilazodone is combined with Benperidol.Approved
Vinyl etherThe risk or severity of adverse effects can be increased when Benperidol is combined with Vinyl ether.Experimental
VortioxetineThe risk or severity of adverse effects can be increased when Vortioxetine is combined with Benperidol.Approved
XenonThe risk or severity of adverse effects can be increased when Benperidol is combined with Xenon.Experimental
XylazineThe risk or severity of adverse effects can be increased when Xylazine is combined with Benperidol.Vet Approved
ZaleplonThe risk or severity of adverse effects can be increased when Zaleplon is combined with Benperidol.Approved, Illicit, Investigational
ZiconotideThe risk or severity of adverse effects can be increased when Benperidol is combined with Ziconotide.Approved
ZimelidineThe risk or severity of adverse effects can be increased when Benperidol is combined with Zimelidine.Withdrawn
ZiprasidoneThe risk or severity of adverse effects can be increased when Ziprasidone is combined with Benperidol.Approved
ZolazepamThe risk or severity of adverse effects can be increased when Zolazepam is combined with Benperidol.Vet Approved
ZolmitriptanThe risk or severity of adverse effects can be increased when Zolmitriptan is combined with Benperidol.Approved, Investigational
ZolpidemBenperidol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.Approved
ZonisamideThe risk or severity of adverse effects can be increased when Benperidol is combined with Zonisamide.Approved, Investigational
ZopicloneThe risk or severity of adverse effects can be increased when Zopiclone is combined with Benperidol.Approved
ZotepineThe risk or severity of adverse effects can be increased when Zotepine is combined with Benperidol.Approved
ZuclopenthixolThe risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Benperidol.Approved, Investigational
Food Interactions
Not Available

References

Synthesis Reference
Not Available
General References
Not Available
External Links
ChemSpider
15521
BindingDB
81492
ChEBI
93403
ChEMBL
CHEMBL297302
ATC Codes
N05AD07 — Benperidol
AHFS Codes
Not Available
PDB Entries
Not Available
FDA label
Not Available
MSDS
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3RecruitingTreatmentAnxiety Disorders / Dementias / Depressive State / Psychosomatic Disorders / Schizophrenic Disorders1
4Active Not RecruitingTreatmentSchizoaffective Disorders / Schizophrenia and Disorders With Psychotic Features / Schizophrenic Disorders1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0306 mg/mLALOGPS
logP3.6ALOGPS
logP3.79ChemAxon
logS-4.1ALOGPS
pKa (Strongest Acidic)11.67ChemAxon
pKa (Strongest Basic)8.55ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area58.36 Å2ChemAxon
Rotatable Bond Count6ChemAxon
Refractivity106.34 m3·mol-1ChemAxon
Polarizability41.85 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
MS/MS Spectrum - , positiveLC-MS/MSsplash10-01b9-3911000000-e206a343ec091deafac6

Taxonomy

Description
This compound belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group.
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organooxygen compounds
Sub Class
Carbonyl compounds
Direct Parent
Alkyl-phenylketones
Alternative Parents
Phenylbutylamines / Butyrophenones / Benzimidazoles / Aryl alkyl ketones / Benzoyl derivatives / Fluorobenzenes / Piperidines / Aryl fluorides / N-substituted imidazoles / Gamma-amino ketones
show 8 more
Substituents
Alkyl-phenylketone / Butyrophenone / Phenylbutylamine / Benzimidazole / Benzoyl / Aryl alkyl ketone / Halobenzene / Fluorobenzene / Aryl fluoride / Aryl halide
show 22 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
Not Available

Drug created on October 20, 2016 18:52 / Updated on September 01, 2017 12:25